SCHEMBL22983091

SCHEMBL22983091

CC(CC[C@@H]1CN(C(=O)O)C(C)(C)C1)(Nc1cccc(S(N)(=O)=O)n1)c1ccccn1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
LMNA P02545 2/20 0.31
TSHR P16473 1/20 0.31
MEN1 O00255 1/20 0.31
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
PTGER2 P43116 2/20 0.31
SCN10A Q9Y5Y9 1/20 0.31
ALDH1A1 P00352 2/20 0.31
DPP4 P27487 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23006678 0.91 TGFBR1 (0.33) CYP19A1NPC1RAB9ACNR1CNR2
SCHEMBL22982322 0.83 CFTR (0.35)
SCHEMBL22982683 0.79 MDM2 (0.32) CNR1CNR2PTGER2SCN10A
SCHEMBL21244591 0.79 SMYD3 (0.34) CA1CA2CA9SCN10A
SCHEMBL21275110 0.79 SMYD3 (0.34) CA1CA2CA9SCN10A
SCHEMBL22982348 0.78 CHRM3 (0.36) CYP19A1CNR1CNR2TSHRMEN1
SCHEMBL22982748 0.78 ALDH1A1 (0.32) CA1CA2CA7MEN1GAA
SCHEMBL23006686 0.78 GPR119 (0.33) CYP19A1CNR1CNR2KDM4EPKM
SCHEMBL22983465 0.78 DPP4 (0.33) CYP19A1CNR1CNR2MEN1GAA
SCHEMBL21244795 0.77 SMYD3 (0.36) CA1CA2CA9MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013759-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2022-06-22 EP disclosed
WO-2021030556-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-02-18 WO disclosed